A Single Blind Study to Evaluate the Safety, Tolerability and Explore the Efficacy of 8.0 mg ASM8 Inhaled Daily for 14 Days in Severe Asthma

Summary

The purpose of the study is to determine the safety and tolerability of 8.0 mg of ASM8 when given daily for 14 days by the Aeroneb® Go nebulizer to subjects with moderate to severe asthma.

Timeline

Start

2011-11

Primary completion

2012-06

Completion

2013-05

Outcome

Outcome not reported

Stopped: “Protocol not progressed. Study not implemented.”

Drugs

Indications